Lund University



The majority of the presenting authors work is focused on a) hemoglobin pathophysiology, with special emphasis on characterizing the role of extracellular hemoglobin and its scavenger system in human diseases; and b) free radical research, emphasizing the importance of redox biology c) A1M, a human endogenous heme and radical scavenger involved in endogenous protection and d) brain damage following preterm intraventricular hemorrhage (IVH). These subject matters are all part of this presentation. Along with the presenting author’s academic research career, he is a senior scientist in the pharmaceutical company A1M Pharma.

The presenting authors work in the field has been recognized in several contexts; including a 3 year position for the research program “Brain damage and neurological impairment in newborns molecular mechanisms, clinical significance and novel therapeutic Interventions”; a 2 year support for the research program “Cell-free hemoglobin, hyperoxia and brain development in newborn infants with congenital heart defect requiring surgery with cardiopulmonary bypass”; the Young Investigator Exchange Program Award, “In recognition of research achievements in pediatrics” by the Society for Pediatric Research in 2014.

I have authored and co-authored 39 publications. Furthermore, I serve as regular editor and reviewer in several international scientific journals in the current research field.